Literature DB >> 9187014

How do men with schizophrenia fare at work? A follow-up study from India.

T N Srinivasan1, R Thara.   

Abstract

Occupational activity, an indicator of the functional status of an individual, is a major component in the long-term management of schizophrenia. The work functioning of 40 first-episode male schizophrenic patients was assessed prospectively every year over a period of 10 years. The comprehensive evaluation of occupational outcome measured in terms of duration of employment, quality of work done, and level of earned income was good in 53% of the patients, comparable to figures from developed countries. This outcome was not related to many of the socio-demographic and clinical variables but was strongly associated with overall clinical, social and marital outcome. The educational and economic status of the study group, the type of work available to them, and the compelling need for men to be the wage-earners in the Indian situation are discussed as influencing the findings of the study.

Entities:  

Mesh:

Year:  1997        PMID: 9187014     DOI: 10.1016/S0920-9964(97)00016-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Consumer perceptions of recovery: an Indian perspective.

Authors:  Rangaswamy Thara
Journal:  World Psychiatry       Date:  2012-10       Impact factor: 49.548

2.  Work functioning of schizophrenia patients in a rural south Indian community: status at 4-year follow-up.

Authors:  Kudumallige K Suresh; Channaveerachari Naveen Kumar; Jagadisha Thirthalli; Somashekar Bijjal; Basappa K Venkatesh; Udupi Arunachala; Kengeri V Kishorekumar; Doddaballapura K Subbakrishna; Bangalore N Gangadhar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-03-15       Impact factor: 4.328

3.  Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China.

Authors:  Mao-Sheng Ran; Xue Weng; Cecilia Lai-Wan Chan; Eric Yu-Hai Chen; Cui-Ping Tang; Fu-Rong Lin; Wen-Jun Mao; Shi-Hui Hu; Yue-Qin Huang; Meng-Ze Xiang
Journal:  Br J Psychiatry       Date:  2015-09-17       Impact factor: 9.319

Review 4.  Cognitive remediation in schizophrenia-The view from India.

Authors:  Smita N Deshpande; Triptish Bhatia; E Mohandas; Vishwajit L Nimgaonkar
Journal:  Asian J Psychiatr       Date:  2016-06-24

5.  Employment outcome for people with schizophrenia in rural v. urban China: population-based study.

Authors:  Lawrence H Yang; Michael R Phillips; Xianyun Li; Gary Yu; Jingxuan Zhang; Qichang Shi; Zhiqiang Song; Zhijie Ding; Shutao Pang; Ezra Susser
Journal:  Br J Psychiatry       Date:  2012-12-20       Impact factor: 9.319

6.  Clinical course and outcome of schizophrenia in a predominantly treatment-naive cohort in rural Ethiopia.

Authors:  Atalay Alem; Derege Kebede; Abebaw Fekadu; Teshome Shibre; Daniel Fekadu; Teferra Beyero; Girmay Medhin; Alemayehu Negash; Gunnar Kullgren
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

Review 7.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

8.  Outcomes that matter: a qualitative study with persons with schizophrenia and their primary caregivers in India.

Authors:  Madhumitha Balaji; Sudipto Chatterjee; Beth Brennan; Thara Rangaswamy; Graham Thornicroft; Vikram Patel
Journal:  Asian J Psychiatr       Date:  2012-07-28

9.  Packages of care for schizophrenia in low- and middle-income countries.

Authors:  Mari Jair de Jesus; Denise Razzouk; Rangaswamy Thara; Julian Eaton; Graham Thornicroft
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

Review 10.  Questioning an axiom: better prognosis for schizophrenia in the developing world?

Authors:  Alex Cohen; Vikram Patel; R Thara; Oye Gureje
Journal:  Schizophr Bull       Date:  2007-09-28       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.